Life360 director John Philip Coghlan sells 4,000 shares

The sales were made under a Rule 10b5-1 plan adopted on December 8, 2025, with each reported price reflecting a weighted average.

Available on EDGAR 11/04/2026 - 05:11 PM EST Accepted by SEC EDGAR 11/04/2026 - 05:11 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Life360, Inc. director John Philip Coghlan reported that the John Coghlan Living Trust sold 4,000 shares of common stock on November 2, 2026: 1,841 shares at a weighted average of $45.29, 1,433 at $46.00, and 726 at $46.69. The sales were made under a Rule 10b5-1 trading plan adopted December 8, 2025. After the transactions, Coghlan reported 5,676 shares held directly, including 3,630 restricted stock units, and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust.

Insider Trade Summary 10b5-1

Net Seller: 4,000 shares

Net Sell 3 txns

Insider COGHLAN JOHN PHILIP

Role Director

Sold 4,000 shs ($183K)

Type	Security	Shares	Price	Value
Sale	Common stock F1, F2	1,841	$45.29	$83K
Sale	Common stock F1, F3	1,433	$46.00	$66K
Sale	Common stock F1, F4	726	$46.69	$34K
Holding	Common stock F5	--	--	--
Holding	Common Stock	--	--	--

Holdings After Transaction: Common stock — 8,431 shares (Indirect, Held by the John Coghlan Living Trust); Common stock — 5,676 shares (Direct); Common Stock — 55,494 shares (Indirect, Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust)

Footnotes (5)

1. F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.
2. F2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.52 to $45.51, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
3. F3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $45.54 to $46.47, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
4. F4. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $46.54 to $46.75, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.
5. F5. Includes 3,630 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Key Figures

Common stock sold: 4,000 shares Sale group and weighted-average price: 1,841 shares at $45.29 per share Sale group and weighted-average price: 1,433 shares at $46.00 per share +4 more

7 metrics

Common stock sold 4,000 shares Three reported sales on November 2, 2026

Sale group and weighted-average price 1,841 shares at $45.29 per share November 2, 2026

Sale group and weighted-average price 1,433 shares at $46.00 per share November 2, 2026

Sale group and weighted-average price 726 shares at $46.69 per share November 2, 2026

Shares held directly 5,676 shares Reported after the November 2, 2026 transactions

Restricted stock units included in direct holdings 3,630 units Each represents a contingent right to receive one common share upon vesting

Shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust 55,494 shares Reported after the November 2, 2026 transactions

Key Terms

Rule 10b5-1 trading plan, weighted average price, restricted stock units, Grantor Retained Annuity Trust

4 terms

Rule 10b5-1 trading plan regulatory

"effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average price financial

"The price reported in Column 4 is the weighted average price"

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

restricted stock units financial

"Includes 3,630 restricted stock units"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Grantor Retained Annuity Trust technical

"The John Philip Coghlan 2025 Grantor Retained Annuity Trust"

A grantor retained annuity trust (GRAT) is an estate-planning tool where the person who creates the trust transfers assets into it but receives fixed cash payments (an annuity) from the trust for a set number of years; whatever remains after that term passes to designated beneficiaries. It matters to investors because it can shift future appreciation of assets out of the creator’s taxable estate—like putting an asset into a timed vending machine that pays you fixed amounts while any extra value that grows inside the machine goes to heirs with reduced gift or estate tax consequences.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What price ranges were reported for the LIF share sales?

The 1,841-share group had a weighted-average price of $45.29, with individual sale prices from $44.52 to $45.51; the 1,433-share group averaged $46.00, with prices from $45.54 to $46.47; and the 726-share group averaged $46.69, with prices from $46.54 to $46.75.

What LIF holdings were reported after the sales?

John Philip Coghlan reported 5,676 shares held directly, including 3,630 restricted stock units, and 55,494 shares held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COGHLAN JOHN PHILIP

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CALIFORNIA 94403

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	11/02/2026		S(1)		1,841	D	$45.29(2)	10,590	I	Held by the John Coghlan Living Trust
Common stock	11/02/2026		S(1)		1,433	D	$46(3)	9,157	I	Held by the John Coghlan Living Trust
Common stock	11/02/2026		S(1)		726	D	$46.69(4)	8,431	I	Held by the John Coghlan Living Trust
Common stock								5,676(5)	D
Common Stock								55,494	I	Held by The John Philip Coghlan 2025 Grantor Retained Annuity Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2025. The Rule 10b5-1 trading plan is a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company.

2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $44.52 to $45.51, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

3. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $45.54 to $46.47, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

4. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices ranging from $46.54 to $46.75, inclusive, per share. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the range.

5. Includes 3,630 restricted stock units, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

Remarks:

	/s/ Jay Sood, as Attorney-in-Fact	11/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)